Bicarbonate Therapy in End-Stage Renal Disease: Current Practice Trends and Implications

Seminars in Dialysis

Volumn 28, Issue 4, 2015, Pages 370-376

  Saikumar, Jagannath H ^a   Kovesdy, Csaba P ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE;

ACIDOSIS; CHRONIC KIDNEY FAILURE; COMPLICATION; HUMAN; PATHOPHYSIOLOGY;

ACIDOSIS; BICARBONATES; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 84935716364     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12373     Document Type: Article

References (91)

1. United States Renal Data System 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Am J Kidney Dis 57(Suppl 1):e1-e526, 2011
2. Warnock DG: Uremic acidosis. Kidney Int 34:278-287, 1988
3. Bailey JL: Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease. Kidney Int Suppl S15-23:2005
4. Widmer B, Gerhardt RE, Harrington JT, Cohen JJ: Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med 139:1099-1102, 1979
5. Gautheir P, Simmons EE, Lemann J: Acidosis of chronic renal failure. In: DuBose TD, Hamm L (eds). Acid-Base and Electrolyte Disorders: A Companion to Brenner and Rector's The Kidney. Philadelphia: Saunders, 2002: 207-216
6. Goodman AD, Lemann J Jr., Lennon EJ, Relman AS: Production, excretion, and net balance of fixed acid in patients with renal acidosis. J Clin Investig 44:495-506, 1965
7. Lemann J Jr., Litzow JR, Lennon EJ: The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Investig 45:1608-1614, 1966
8. Kovesdy CP: Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Nephrol Dial Transplant 27:3056-3062, 2012
9. Williams B, Hattersley J, Layward E, Walls J: Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 40:779-786, 1991
10. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Investig 95:39-45, 1995
11. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Investig 97:1447-1453, 1996
12. May RC, Bailey JL, Mitch WE, Masud T, England BK: Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 49:679-683, 1996
13. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20:2075-2084, 2009
14. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, Goodship TH: Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396-1400, 1996
15. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Cancarini GC, Scolari F, Feller P, Maiorca R: Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 13:1719-1722, 1998
16. Movilli E, Bossini N, Viola BF, Camerini C, Cancarini GC, Feller P, Strada A, Maiorca R: Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. Nephrol Dial Transplant 13:674-678, 1998
17. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632-637, 1997
18. Alpern RJ, Sakhaee K: The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 29:291-302, 1997
19. Lefebvre A, de Vernejoul MC, Gueris J, Goldfarb B, Graulet AM, Morieux C: Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 36:1112-1118, 1989
20. Mathur RP, Dash SC, Gupta N, Prakash S, Saxena S, Bhowmik D: Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail 28:1-5, 2006
21. Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship TH: Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 8:627-631, 1997
22. DeFronzo RA, Smith D, Alvestrand A: Insulin action in uremia. Kidney Int Suppl 16:S102-S114, 1983
23. Kaptein EM: Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17:45-63, 1996
24. Mahesh S, Kaskel F: Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23:41-48, 2008
25. Anantharaman P, Schmidt RJ: Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 14:119-125, 2007
26. Yavuz D, Topcu G, Ozener C, Akalin S, Sirikci O: Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy. Clin Endocrinol 63:520-524, 2005
27. Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, O'Donoghue DJ, Kalra PA: Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J 82:693-696, 2006
28. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, Wesson DE: Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 77:617-623, 2010
29. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE: Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78:303-309, 2010
30. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A: Effect of diet on plasma acid-base composition in normal humans. Kidney Int 24:670-680, 1983
31. 2 concentration in chronic kidney disease: modification of diet in renal disease study findings. Clin J Am Soc Nephrol 1:52-57, 2006
32. Barsotti G, Cupisti A, Ciardella F, Morelli E, Niosi F, Giovannetti S: Compliance with protein restriction: effects on metabolic acidosis and progression of renal failure in chronic uremics on supplemented diet. Contrib Nephrol 81:42-49, 1990
33. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
34. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE: Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 27:652-663, 1996
35. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S: Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 10:2426-2439, 1999
36. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 124:627-632, 1996
37. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY: Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 304:216-220, 1992
38. K/DOQI NKF: Clinical Practice Guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35: 1-140, 2000
39. Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA: Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 6:63-70, 1987
40. Daugirdas JT: Dialysis hypotension: a hemodynamic analysis. Kidney Int 39:233-246, 1991
41. Gennari FJ: Acid-base balance in dialysis patients. Kidney Int 28:678-688, 1985
42. Wolff J, Pedersen T, Rossen M, Cleemann-Rasmussen K: Effects of acetate and bicarbonate dialysis on cardiac performance, transmural myocardial perfusion and acid-base balance. Int J Artif Organs 9:105-110, 1986
43. Nixon JV, Mitchell JH, McPhaul JJ Jr., Henrich WL: Effect of hemodialysis on left ventricular function. Dissociation of changes in filling volume and in contractile state. J Clin Investig 71:377-384, 1983
44. Mehta BR, Fischer D, Ahmad M, Dubose TD Jr.: Effects of acetate and bicarbonate hemodialysis on cardiac function in chronic dialysis patients. Kidney Int 24:782-787, 1983
45. Anderson LE, Nixon JV, Henrich WL: Effects of acetate and bicarbonate dialysate on left ventricular performance. Am J Kidney Dis 10:350-355, 1987
46. Hampl H, Klopp HW, Michels N, Mahiout A, Schilling H, Wolfgruber M, Schiller R, Hanefeld F, Kessel M: Electroencephalogram investigations of the disequilibrium syndrome during bicarbonate and acetate dialysis. Proc Eur Dial Transplant Assoc 19:351-359, 1983
47. Bland LA, Ridgeway MR, Aguero SM, Carson LA, Favero MS: Potential bacteriologic and endotoxin hazards associated with liquid bicarbonate concentrate. ASAIO Trans 33:542-545, 1987
48. Ebben JP, Hirsch DN, Luehmann DA, Collins AJ, Keshaviah PR: Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis. ASAIO Trans 33:269-273, 1987
49. Suri R, Kliger A: Frequent hemodialysis: physiological, epidemiological and practical aspects. In: Himmelfarb J, Sayegh MH (eds). Chronic Kidney Disease, Dialysis and Transplantation, 3rd ed. ???: Saunders, 2010: 357
50. Locatelli F, Covic A, Chazot C, Leunissen K, Luno J, Yaqoob M: Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 19:785-796, 2004
51. Sam R, Vaseemuddin M, Leong WH, Rogers BE, Kjellstrand CM, Ing TS: Composition and clinical use of hemodialysates. Hemodial Int 10:15-28, 2006
52. Meyer KB: Dialysate bicarbonate: the case for foot-dragging. Am J Kidney Dis 62:650-652, 2013
53. Thews O: Model-based decision support system for individual prescription of the dialysate bicarbonate concentration in hemodialysis. Int J Artif Organs 15:447-455, 1992
54. Thews O, Hutten H: A comprehensive model of the dynamic exchange processes during hemodialysis. Med Prog Technol 16:145-161, 1990
55. Heineken FG, Brady-Smith M, Haynie J, Van Stone JC: Prescribing dialysate bicarbonate concentrations for hemodialysis patients. Int J Artif Organs 11:45-50, 1988
56. Klein E, Autian J, Bower JD, Buffaloe G, Centella LJ, Colton CK, Darby TD, Farrell PC, Holland FF, Kennedy RS, Lipps B Jr., Mason R, Nolph KD, Villarroel F, Wathen RL: Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter five. Evaluation of toxicity potential of hemodialyzers. Artif Organs 2:284-292, 1978
57. Fernandez PC, Cohen RM, Feldman GM: The concept of bicarbonate distribution space: the crucial role of body buffers. Kidney Int 36:747-752, 1989
58. Pellet M: Physiologie Humaine I. Paris: SIMEP, 1977
59. -, and pH in hemodialyzed uremic patients. Ren Fail 27:235-238, 2005
60. Agroyannis B, Fourtounas C, Tzanatos H, Dalamangas A, Vlahakos DV: Relationship between interdialytic weight gain and acid-base status in hemodialysis by bicarbonate. Artif Organs 26:385-387, 2002
61. Morel H, Jaffrin MY, Lux C, Renou M, Fessier C, Petit A, Moriniere P, Legallais C: A comparison of bicarbonate kinetics and acid-base status in high flux hemodialysis and on-line post-dilution hemodiafiltration. Int J Artif Organs 35:288-300, 2012
62. Ledebo I: Acid-base correction and convective dialysis therapies. Nephrol Dial Transplant 15(Suppl 2):45-48, 2000
63. Heguilen RM, Sciurano C, Bellusci AD, Fried P, Mittelman G, Rosa Diez G, Bernasconi AR: The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Nephrol Dial Transplant 20:591-597, 2005
64. Zhang H, Schaubel DE, Kalbfleisch JD, Bragg-Gresham JL, Robinson BM, Pisoni RL, Canaud B, Jadoul M, Akiba T, Saito A, Port FK, Saran R: Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int 81:1108-1115, 2012
65. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365:1099-1107, 2011
66. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268-2273, 2006
67. Graziani G, Casati S, Passerini P, Crepaldi M, Campise M, Ambroso G: Pathophysiology and clinical consequences of metabolic alkalosis in hemodialyzed patients. Arch Ital Urol Nefrol Androl 59: 105-111, 1987
68. Gabutti L, Ferrari N, Giudici G, Mombelli G, Marone C: Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. Nephrol Dial Transplant 18:2369-2376, 2003
69. Gabutti L, Ross V, Duchini F, Mombelli G, Marone C: Does bicarbonate transfer have relevant hemodynamic consequences in standard hemodialysis? Blood Purif 23:365-372, 2005
70. Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M: Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant 24:973-981, 2009
71. Kaye M, Somerville PJ, Lowe G, Ketis M, Schneider W: Hypocalcemic tetany and metabolic alkalosis in a dialysis patient: an unusual event. Am J Kidney Dis 30:440-444, 1997
72. Sethi D, Curtis JR, Topham DL, Gower PE: Acute metabolic alkalosis during haemodialysis. Nephron 51:119-120, 1989
73. Noris M, Todeschini M, Casiraghi F, Roccatello D, Martina G, Minetti L, Imberti B, Gaspari F, Atti M, Remuzzi G: Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. Am J Kidney Dis 32:115-124, 1998
74. Grandi E, Govoni M, Furini S, Severi S, Giordano E, Santoro A, Cavalcanti S: Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath. Nephrol Dial Transplant 23:2192-2197, 2008
75. Noh US, Yi JH, Han SW, Kim HJ: Varying dialysate bicarbonate concentrations in maintenance hemodialysis patients affect post-dialysis alkalosis but not pre-dialysis acidosis. Electrolyte Blood Press 5:95-101, 2007
76. Oettinger CW, Oliver JC: Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. J Am Soc Nephrol 3:1804-1807, 1993
77. Alfakir M, Moammar MQ, Ali MI, Alhatem E, Curran RD, Saoud RM, Chandran C, Khan MA, Debari VA: Pulmonary gas exchange during hemodialysis: a comparison of subjects with and without COPD on bicarbonate hemodialysis. Ann Clin Lab Sci 41:315-320, 2011
78. De Broe ME, Heyrman RM, De Backer WA, Verpooten GA, Vermeire PA: Pathogenesis of dialysis-induced hypoxemia: a short overview. Kidney Int Suppl 24:S57-S61, 1988
79. Jacob AI, Gavellas G, Zarco R, Perez G, Bourgoignie JJ: Leukopenia, hypoxia, and complement function with different hemodialysis membranes. Kidney Int 18:505-509, 1980
80. Pitcher WD, Diamond SM, Henrich WL: Pulmonary gas exchange during dialysis in patients with obstructive lung disease. Chest 96:1136-1141, 1989
81. Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol 1:70-78, 2006
82. Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torlen K, Mehrotra R: Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol 8:254-264, 2013
83. Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW: Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44:661-671, 2004
84. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
85. Chauveau P, Fouque D, Combe C, Laville M, Canaud B, Azar R, Cano N, Aparicio M, Leverve X: Acidosis and nutritional status in hemodialyzed patients. French Study Group for Nutrition in Dialysis. Semin Dial 13:241-246, 2000
86. Messa P, Mioni G, Maio GD, Ferrando C, Lamperi D, Famularo A, Paoletti E, Cannella G: Derangement of acid-base balance in uremia and under hemodialysis. J Nephrol 14(Suppl 4):S12-S21, 2001
87. Chen JL, Kalantar-Zadeh K: Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial 27:259-262, 2014
88. Care FM: Internal Memo: Dialysate Bicarbonate, Alkalosis and Patient Safety. Available at http://graphics8.nytimes.com/packages/pdf/business/fresenius-memo.pdf, accessed March 27, 2015
89. Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, Ikizler TA, Rayner H, Fissell RB, Vanholder R, Tomo T, Port FK: Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 62:738-746, 2013
90. Kovesdy CP, Kalantar-Zadeh K: Observational studies versus randomized controlled trials: avenues to causal inference in nephrology. Adv Chronic Kidney Dis 19:11-18, 2012
91. Checherita IA, David C, Ciocalteu A, Lascar I, Budala L: Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status. Rom J Morphol Embryol 54:539-543, 2013